Nitric oxide (NO) is a new clinical biomarker of survival in the elderly patients and its efficacy might be nearly equal to albumin.

@article{Osawa2007NitricO,
  title={Nitric oxide (NO) is a new clinical biomarker of survival in the elderly patients and its efficacy might be nearly equal to albumin.},
  author={Masako Osawa and Toshio Hayashi and Hideki Nomura and Jun Funami and Asaka Miyazaki and Louis Joseph Ignarro and Akihisa Iguchi},
  journal={Nitric oxide : biology and chemistry},
  year={2007},
  volume={16 1},
  pages={157-63}
}
BACKGROUND For elderly patients, the consideration of prognostic factors is very important, but there have been few reports about the potential use of vasoactive substances as prognostic markers in the elderly. OBJECTIVE We assessed endocrinological substances, such as plasma NO(x) (metabolites of NO), as the prognostic marker in elderly. We compared their efficacy with that of such well-known markers as albumin and pro-inflammatory cytokines such as IL-6. METHODS The patients were… CONTINUE READING